The multidrug resistance-associated protein (MRP) is over-expressed and functional in rat hepatoma cells

International Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 479-485

  Payen, Léa ^a,b   Courtois, Arnaud ^a,b   Vernhet, Laurent ^a   Guillouzo, André ^a   Fardel, Olivier ^a,b  

^a INSERM   (France)

^b Institute de Chimie de'Rennes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIETHYLNITROSAMINE; INDOMETACIN; MULTIDRUG RESISTANCE PROTEIN; PROBENECID; VERAPAMIL; VINCRISTINE; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; DETOXIFICATION; GENE OVEREXPRESSION; HEPATOMA CELL; LIVER CELL CARCINOMA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 0032946379     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990505)81:3<479::AID-IJC24>3.0.CO;2-S     Document Type: Article

References (30)

1. BEAUMONT, C., LERUMEUR, E., GUILLOUZO, C. LATINIER, M.F., BOUREL, M. and GUILLOUZO, A., Ferritin is increased in diethylnitrosamine altered rat hepatocytes. Biochem. Biophys. Res. Commun., 99, 879-885 (1981).
2. BOYER, J.L., HAGENBUCH, B., ANANTHANARAYANAN, M., SUCHY, F., STIEGER, B. and MEIER, P.J., Phylogenic and ontogenic expression of hepatocellular bile acid transport. Proc. nat. Acad. Sci. (Wash.), 90, 435-438 (1993).
3. CARR, B.I., Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats. Cancer Res., 47, 5577-5583 (1987).
4. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung-cancer cell line. Science, 258, 1650-1654 (1992).
5. DESCHATRETTE, J. and WEISS, M.C., Characterization of differentiated and dedifferentiated clones from a rat hepatoma. Biochimie, 56, 1603-1611 (1974).
6. DRAPER, M.P., MARTELL, R.L. and LEVY, S.B., Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Brit. J. Cancer, 75, 810-881 (1997).
7. ERICKSSON, L.C. and ANDERSSON, G.N., Membrane biochemistry and chemical hepatocarcinogenesis. Crit. Rev. Biochem., 27, 1-55 (1992).
8. FARBER, E. and SARMA, D.S.R., Hepatocarcinogenesis: a dynamic cellular perspective. Lab. Invest., 56, 4-21 (1990).
9. FARDEL, O., LOYER, P., LECUREUR, V., GLAISE, D. and GUILLOUZO, A., Constitutive expression of functional P-glycoprotein in rat hepatoma cells. Europ. J. Biochem., 219, 521-528 (1994).
10. FELLER, N., BROXTERMAN, H.J., WAHRER, D.C. and PINEDO, H.M., ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett., 368, 385-388 (1995).
11. FURUYA, K.N., BRADLEY, G., SUN, D., SCHUETZ, E.G. and SCHUETZ, J.D., Identification of a new P-glycoprotein-like ATP-binding cassette transporter gene that is overexpresscd during hepatocarcinogenesis. Cancer Res., 57, 3708-3716 (1997).
12. GERMANS, U.A., GOTTESMAN, M.M. and PASTAN, I., Expression of a multidrug resistance-adenosine deaminase fusion gene. J. biol. Chem., 264, 7418-7424 (1989).
13. GOTTESMAN, M.M., Multidrug resistance during chemical carcinogenesis: a mechanism revealed? J. nat. Cancer Inst., 80, 1352-1353 (1988).
14. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of MDR mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
15. HUANG, C., WU, M., XU, G., LI, D., CHENG, H., TU, Z., JIANG, H. and GU, J., Overexpression of the MDRI gene and P-glycoprotein in human hepatocellular carcinoma. J. nat. Cancer Inst., 84, 260-262 (1992).
16. KRISHNAMACHARY, N., MA, L., ZHENG, L., SAFA, A.R. and CENTER, M.S., Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin. Oncol. Res., 6, 119-127 (1994).
17. LAUTIER, D., CANITROT, Y., DEELEY, R.G. and COLE, S.P.C., Multidrug resistance mediated bv the multidrug resistance protein (MRP) gene. Biochem. Pharmacol. 52, 967-977 (1996).
18. LECUREUR, V., GUILLOUZO, A. and FARDEL, O., Differential expression of the polyspecific drug transporter OCT1 in rat hepalocarcinoma cells. Cancer Lett., 126, 227-233 (1998).
19. 1 and its glutathione conjugates by the product of the multidrug-resistance protein (MRP) gene. Mol. Pharmacol., 51, 1034-1041 (1997).
20. MAYER, R., KARTENBECK, J., BÜCHLER, M., JEDLITSCHKY, G., LEIER, I. and KEPPLER, D., Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol., 131, 137-150 (1995).
21. NERENSTONE, S.R., IHDE, D.C. and FRIEDMAN, M.A., Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat. Rev., 15, 1-31 (1988).
22. PAULUSMA, C.C., BOSMA, P.J., ZAMAN, G.J., BAKKER, C.T., OTTER, M., SCHEFFER, G.L., SCHEPER, R.J., BORST, P. and OUDE ELFERINK, R.P., Congenital jaundice in rats with a mutation in a multidrug resistance associated protein gene. Science, 271, 1126-1128 (1996).
23. PEMBLE, S.E., TAYLOR, J.B. and KETTERER, B., Tissue distribution of rat glutathione-transferase subunit 7, a hepatoma marker. Biochem. J., 240, 885-889 (1986).
24. RIORDAN, J.R., DEUCHARS, K., KARTNER, N., ALAR, N., TRENT, J. and LING, V., Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (Lond.), 316, 817-819 (1985).
25. ROELOFSEN, H., VOS, T.A., SCHIPPERS, I.J., KUIPERS, F., KONING, H., MOSHAGE, H., JANSEN, P.L. and MULLER, M., Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology, 112, 511-521 (1997).
26. SONG, R., IKEGUCHI, M., ZHOU, G. and KUO, M.T., Identification and characterization of a hepatoma cell-specific enhancer in the mouse multidrug resistance mdr1b promoter. J. biol. Chem., 270, 25468-25474 (1995).
27. SPIEWAK-RINAUDO, J.A. and FARBER, R., The pattern of metabolism of 2-acetylaminofluorene in carcinogen-induced hepatocyte nodules in comparison to normal liver. Carcinogenesis, 7, 523-528 (1986).
28. THOMPSON, E.B., TOMKINS, G.M. and CURRAN, J.E. Induction of tyrosine ketoglutarate transaminase by steroid hormones in a newly established tissue-culture cell line. Biochemistry, 56, 296-303 (1966).
29. THORGEIRSSON, S.S., SILVERMAN, J.A., GANT, T.W. and MARINO, P., Multidrug resistance-gene family and chemical carcinogens. Pharmac. Ther., 49, 283-292 (1991).
30. VAN LUYN, M.J., MULLER, M., RENES, J., MEIJER, C., SCHEPER, R.J., NIENHUIS, E.F., MULDER, N.H., JANSEN, P.L. and DE VRIES, E.G.E., Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1. Int. J. Cancer. 76, 55-62 (1998).